InspireMD, Inc. announced on September 17, 2025, the appointment of Dan Dearen to its Board of Directors. Mr. Dearen brings nearly 40 years of leadership experience in the medical device and life sciences sectors, with a proven track record of guiding MedTech companies through critical financial milestones.
Mr. Dearen previously served as President, co-Founder, and Chief Financial Officer of Axonics, Inc., which went public and was later acquired by Boston Scientific for $3.7 billion in November 2024. His financial expertise and strategic insight are expected to be valuable as InspireMD advances its mission to lead the carotid intervention market.
CEO Marvin Slosman noted that Mr. Dearen's arrival is perfectly timed as the company continues its U.S. commercial launch of CGuard Prime and works to advance its position in the market. This appointment follows the addition of Raymond W. Cohen to the Board in July 2025, further strengthening the company's governance and strategic capabilities.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.